Production (Stage)
ProKidney Corp.
PROK
$0.9565
$0.169521.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.73M | -21.28M | -17.91M | -12.51M | -9.49M |
| Total Depreciation and Amortization | 1.60M | 1.57M | 1.49M | 1.27M | 1.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.57M | -22.02M | -12.55M | -19.54M | -20.45M |
| Change in Net Operating Assets | 1.11M | 17.56M | -269.00K | -7.52M | -5.81M |
| Cash from Operations | -29.59M | -24.17M | -29.24M | -38.29M | -34.65M |
| Capital Expenditure | -1.14M | -25.51M | -2.40M | -636.00K | -960.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.42M | 40.59M | -79.23M | 29.21M | 59.36M |
| Cash from Investing | 28.29M | 15.08M | -81.64M | 28.57M | 58.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.00K | -14.00K | -14.00K | -13.00K | -13.00K |
| Issuance of Common Stock | -- | 137.00K | 4.47M | 139.86M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.00K | 123.00K | 4.46M | 139.84M | -13.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.32M | -8.97M | -106.42M | 130.12M | 23.74M |